Editorial: European Union's research policy: A moving target?

Tropical Medicine and International Health

Volumn 6, Issue 11, 2001, Pages 843-844

  Boelaert, M ^a   Matthys, F ^b   Henkens, M ^b   D'Alessandro, U ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; EFLORNITHINE; FANSIDAR; ANTIMALARIAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN TRYPANOSOMIASIS; ANTIBIOTIC RESISTANCE; COMMUNICABLE DISEASE; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG RESEARCH; ECONOMICS; EDITORIAL; EUROPEAN UNION; HEALTH CARE ACCESS; HELMINTHIASIS; INFECTION CONTROL; LEISHMANIASIS; MALARIA; MALARIA CONTROL; MORTALITY; POLICY; POVERTY; TROPICAL DISEASE; TUBERCULOSIS; DRUG RESISTANCE; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; LEGAL ASPECT; RESEARCH;

ANTIMALARIALS; DRUG RESISTANCE; EUROPEAN UNION; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA; RESEARCH; WORLD HEALTH;

EID: 0035516050     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00796.x     Document Type: Editorial

References (8)

1. A global health fund: Heeding Koch's caution
2. Availability and affordability of treatment for Human African Trypanosomiasis
3. Drugs for neglected diseases: A failure of the market and a public health failure?